Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements

Name: Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2021-07-29

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (French, HTML) HTML
Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (English, HTML) HTML

Related open data

Health Canada